These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 522817)

  • 21. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
    Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study.
    G Ital Cardiol; 1989 Jan; 19(1):71-80. PubMed ID: 2663585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and pharmacodynamics of muzolimine in chronic heart failure.
    Storstein L; Bjørnstad H; Mølstad P
    Z Kardiol; 1985; 74 Suppl 2():34-6. PubMed ID: 4002802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure].
    Wutte M; Hülsmann M; Berger R; Rödler S; Frey B; Stanek B; Pacher R
    Wien Klin Wochenschr; 1998 Jul; 110(13-14):473-8. PubMed ID: 9746960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Meproscillarin, a new semisynthetic cardiac glycoside/chemistry and physical properties (author's transl)].
    Kubinyi H
    Arzneimittelforschung; 1978; 28(3a):493-5. PubMed ID: 580577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Butofilolol pharmacokinetics in chronic renal insufficiency.
    Jeanniot JP; Houin G; Ledudal P; Cautreels W; Giudicelli CP; Tillement JP
    Int J Clin Pharmacol Res; 1984; 4(3):165-73. PubMed ID: 6149194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of pengitoxin and its therapeutic efficacy in congestive heart failure.
    Haustein KO; Wesser M
    Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):8-15. PubMed ID: 3403092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First clinical trial with etomoxir in patients with chronic congestive heart failure.
    Schmidt-Schweda S; Holubarsch C
    Clin Sci (Lond); 2000 Jul; 99(1):27-35. PubMed ID: 10887055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preliminary hemodynamic studies on the activity of meproscillarin (author's transl)].
    Klein WW; Pavek P
    Arzneimittelforschung; 1978; 28(3a):553-5. PubMed ID: 580588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure.
    Arimoto T; Takeishi Y; Niizeki T; Takabatake N; Okuyama H; Fukui A; Tachibana H; Nozaki N; Hirono O; Tsunoda Y; Miyashita T; Shishido T; Takahashi H; Koyama Y; Kubota I
    J Card Fail; 2005 Oct; 11(8):595-601. PubMed ID: 16230262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failure.
    Mortensen SA; Vadhanavikit S; Baandrup U; Folkers K
    Drugs Exp Clin Res; 1985; 11(8):581-93. PubMed ID: 3836876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term study with the novel cardiac glycoside meproscillarin (author's transl)].
    Eckardt A; Koch W; Safer A
    Arzneimittelforschung; 1978; 28(3a):570-3. PubMed ID: 348206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic trial of an association of theophylline and proscillaridin A in the treatment of cor pulmonale and of some decompensated heart diseases].
    Ballerini C; Fontana A
    Minerva Med; 1971 Mar; 62(23):1225-37. PubMed ID: 5103269
    [No Abstract]   [Full Text] [Related]  

  • 35. [Relation between serum levels and inotropic effect of digoxin in advanced cardiac failure during long-term treatment].
    Geslin P; Pézard P; Galland F; Tadei A
    Arch Mal Coeur Vaiss; 1983 Dec; 76(12):1399-408. PubMed ID: 6422876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical experience with the cardiac glycoside Gitoformat (author's transl)].
    Benda L; Zenz W
    Med Klin; 1978 Jul; 73(30):1081-4. PubMed ID: 672762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical experience in the use of proscillaridin A in cardiac patients with tubercular bronchopneumopathy].
    Concina E; Spataro C; Migliaccio A; Piacenza G
    Minerva Med; 1971 Apr; 62(34):1769-82. PubMed ID: 5103638
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical pharmacokinetics of digoxin in Nigerians.
    Iyun AO; Lukanbi FA
    Afr J Med Med Sci; 1988 Mar; 17(1):9-15. PubMed ID: 2834936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [24-hour blood pressure and renal function in cardiac failure during the titration phase of captopril and enalapril].
    Osterziel KJ; Dietz R; Abushi A; Kübler W
    Z Kardiol; 1990 Nov; 79(11):742-7. PubMed ID: 2278166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
    Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B
    Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.